Sign in
close
Username or email
*
Password
*
Log in
No account yet?
Create an Account
Search for:
Search
MICRO-IMMUNOTHERAPY
Low-dose immunotherapy
The immune system
Testimonials
Share your experience
Find your doctor
Clinics and health centers
Documents
Brochures for patients & general public
Scientific studies
THERAPEUTIC AREAS
OUR ACTIVITIES
Trainings and events
Join our Professional Area
Micro-immunotherapy in other languages
BLOG
Healthy lifestyle
Micro-immunotherapy news
Fields of application
ABOUT US
About us
Contact us
Cooperations
Micro-immunotherapy in other countries
AEMI
MEGEMIT
IFMI
PROFESSIONAL AREA
Login / Register
Shopping cart
close
DE
ES
FR
Professional Area
DE
ES
FR
Login / Register
close
Search for:
Search
Cart (
o
)
0
/
0,00
€
MICRO-IMMUNOTHERAPY
Low-dose immunotherapy
The immune system
Testimonials
Share your experience
Find your doctor
Clinics and health centers
Documents
Brochures for patients & general public
Scientific studies
THERAPEUTIC AREAS
OUR ACTIVITIES
Trainings and events
Join our Professional Area
Micro-immunotherapy in other languages
BLOG
Healthy lifestyle
Micro-immunotherapy news
Fields of application
ABOUT US
About us
Contact us
Cooperations
Micro-immunotherapy in other countries
AEMI
MEGEMIT
IFMI
Search for:
Search Button
Keywords:
Micro-immunotherapy
Benefits of using vitamin C and micro-immunotherapy in the management of infections
Is the Epstein-Barr virus the cause or the consequence of the COVID-19 infection?
Potential Role of the Micro-Immunotherapy Medicine 2LALERG in the Treatment of Pollen-Induced Allergic Inflammation
Micro-immunotherapy & oncology
Well-Aging and micro-immunotherapy
Epstein-Barr virus infections & micro-immunotherapy
Clinical efficacy of 2L®ALERG, a new sublingual immunomodulatory treatment, in seasonal allergic rhinitis: A double-blind placebo-controlled study
The Micro-Immunotherapy Medicine 2LARTH® Reduces Inflammation and Symptoms of Rheumatoid Arthritis In Vivo
Effect of 2LMISEN® on Long-Term Hippocampal Neurons Culture as a Screening Senescent Cells Model: p16INK4A and Caspase 3 Quantification
Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease
Previous
1
2
3
4
5
6
Next
Scroll To Top
